IL164196A0 - 4-(Diarylmethyl)-1-piperazinyl derivatives - Google Patents

4-(Diarylmethyl)-1-piperazinyl derivatives

Info

Publication number
IL164196A0
IL164196A0 IL16419603A IL16419603A IL164196A0 IL 164196 A0 IL164196 A0 IL 164196A0 IL 16419603 A IL16419603 A IL 16419603A IL 16419603 A IL16419603 A IL 16419603A IL 164196 A0 IL164196 A0 IL 164196A0
Authority
IL
Israel
Prior art keywords
sub
substituted
aryl
groups
heteroaryl
Prior art date
Application number
IL16419603A
Other languages
English (en)
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of IL164196A0 publication Critical patent/IL164196A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16419603A 2002-03-27 2003-03-27 4-(Diarylmethyl)-1-piperazinyl derivatives IL164196A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN302MU2002 2002-03-27
PCT/IN2003/000089 WO2003079970A2 (en) 2002-03-27 2003-03-27 4-(diarylmethyl)-1-piperazinyl derivatives

Publications (1)

Publication Number Publication Date
IL164196A0 true IL164196A0 (en) 2005-12-18

Family

ID=28053441

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16419603A IL164196A0 (en) 2002-03-27 2003-03-27 4-(Diarylmethyl)-1-piperazinyl derivatives

Country Status (24)

Country Link
US (1) US7297697B2 (xx)
EP (1) EP1487810B9 (xx)
JP (1) JP4454314B2 (xx)
KR (1) KR100995557B1 (xx)
CN (1) CN100340551C (xx)
AT (1) ATE457983T1 (xx)
AU (1) AU2003231921B8 (xx)
BR (1) BR0308913A (xx)
CA (1) CA2480367C (xx)
CY (1) CY1110038T1 (xx)
DE (1) DE60331295D1 (xx)
DK (1) DK1487810T3 (xx)
EA (1) EA007794B1 (xx)
EG (1) EG24927A (xx)
ES (1) ES2341236T3 (xx)
IL (1) IL164196A0 (xx)
MX (1) MXPA04009387A (xx)
NZ (1) NZ535476A (xx)
PL (1) PL375439A1 (xx)
PT (1) PT1487810E (xx)
SI (1) SI1487810T1 (xx)
UA (1) UA76609C2 (xx)
WO (1) WO2003079970A2 (xx)
ZA (1) ZA200407731B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4782441B2 (ja) * 2005-02-28 2011-09-28 勤 竹内 ジフェニルメチルピペラジン誘導体及びそれを含有する医薬組成物
EP2041088B1 (en) 2006-06-28 2014-01-08 Amgen Inc. Glycine transporter-1 inhibitors
CN106309443B (zh) * 2016-07-26 2021-01-22 上海璃道医药科技有限公司 二苯甲烷类药物的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2082168A5 (en) * 1970-03-05 1971-12-10 Aries Robert (-1-benzhydryl-4-piperazinyl)-alkoxy-alkyl esters of benzoic - or phenyl-alkanoic acids - analgesic, antipyretic, sympathomimetic,
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
AU658656B2 (en) 1991-07-19 1995-04-27 Zeria Pharmaceutical Co., Ltd. 4-phenylmethylpiperazine derivatives and their use as antiallergic and antihistaminic agents
JP3352184B2 (ja) * 1993-11-12 2002-12-03 株式会社アズウェル ピペラジン不飽和脂肪酸誘導体
PE20001566A1 (es) * 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6239277B1 (en) * 1999-10-20 2001-05-29 Salsbury Chemicals, Inc. Process for preparing piperazine-substituted aliphatic carboxylates
GB0009479D0 (en) * 2000-04-17 2000-06-07 Cipla Limited Antihistaminic compounds

Also Published As

Publication number Publication date
JP4454314B2 (ja) 2010-04-21
CN1649856A (zh) 2005-08-03
EP1487810A2 (en) 2004-12-22
EG24927A (en) 2011-01-02
US20050107393A1 (en) 2005-05-19
ES2341236T3 (es) 2010-06-17
EA200401259A1 (ru) 2005-02-24
ZA200407731B (en) 2006-02-22
EA007794B1 (ru) 2007-02-27
CY1110038T1 (el) 2015-01-14
WO2003079970A8 (en) 2005-03-24
PT1487810E (pt) 2010-04-27
CA2480367A1 (en) 2003-10-02
CA2480367C (en) 2011-01-25
CN100340551C (zh) 2007-10-03
DE60331295D1 (de) 2010-04-01
JP2005527533A (ja) 2005-09-15
BR0308913A (pt) 2005-01-04
SI1487810T1 (sl) 2010-06-30
EP1487810B1 (en) 2010-02-17
EP1487810B9 (en) 2011-02-23
DK1487810T3 (da) 2010-05-17
AU2003231921A1 (en) 2003-10-08
WO2003079970A3 (en) 2003-11-06
KR100995557B1 (ko) 2010-11-22
NZ535476A (en) 2006-03-31
ATE457983T1 (de) 2010-03-15
KR20040101368A (ko) 2004-12-02
WO2003079970A2 (en) 2003-10-02
AU2003231921B8 (en) 2009-04-02
MXPA04009387A (es) 2005-01-25
US7297697B2 (en) 2007-11-20
UA76609C2 (en) 2006-08-15
AU2003231921B2 (en) 2008-11-13
PL375439A1 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
TW200606137A (en) Urea derivatives
RS20060079A (xx) Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma
RS51674B (en) PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS
WO2001038324A3 (en) Imidazole derivatives and their use as raf kinase inhibitors
EP1490371A4 (en) TRICYCLIC COMPOUNDS BASED ON THIOPENE AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS
GB0113233D0 (en) Chemical compounds
MY126139A (en) Piperidine compounds for use as ccr-3 inhibitors
FI931763A0 (fi) 4,1-bensoxazepinderivat och deras anvaendning
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
PT1363875E (pt) Novos derivados de benzamidina com actividade anti-inflamatória e imunosupressora
EG24927A (en) (diarylmethyl)-1-piperazinyl derivatives
ES8707226A1 (es) Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol
DE69402703D1 (de) 3-(INDOL-3-YL) PROPENSäURDERIVATE, DIE ALS NMDA- ANTAGONISTEN NÜTZLICH SIND
AU656207B2 (en) Antihypertensive combination
ATE268769T1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees